Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Live Skin Bacteria Shown to Control Acne

First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition. . . . → Read More: Live Skin Bacteria Shown to Control Acne

Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

First Trial of Alzheimer’s Drug Underway

The first clinical trial is underway of a therapy for stopping the progression of Alzheimer’s disease that purports to rebuild neural connections in the brain. . . . → Read More: First Trial of Alzheimer’s Drug Underway

Univ. Spin-Off Reports Cancer Immunotherapy Advance

A highly targeted synthetic antibody, developed by a university spin-off enterprise, was shown to destroy human breast cancer cells grafted in lab mice. . . . → Read More: Univ. Spin-Off Reports Cancer Immunotherapy Advance

Online Game Harnessed to Combat Foodborne Toxins

A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops. . . . → Read More: Online Game Harnessed to Combat Foodborne Toxins

Roche, Biotech to Discover New Antibiotics

A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics. . . . → Read More: Roche, Biotech to Discover New Antibiotics

Biotech Licenses Gene Editing for Autoimmune Disorders

A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases. . . . → Read More: Biotech Licenses Gene Editing for Autoimmune Disorders

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds

Avian Flu Vaccine with Longer Protection in Development

A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines. . . . → Read More: Avian Flu Vaccine with Longer Protection in Development

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals